Table 3 |
|||
|
Standardized mean differences (SMD) for changes from baseline grouped by acute or chronic condition. |
|||
|
No. of treatment arms |
SMD (95% confidence Interval) |
I2 (%) |
|
|
|
|||
|
No treatment |
|||
|
|
|||
|
Acute |
10 |
-0.56 (-0.85 to -0.26) |
41 |
|
Chronic |
27 |
-0.24 (-0.33 to -0.14) |
0 |
|
Placebo |
|||
|
|
|||
|
Acute |
10 |
-0.65 (-1.03 to -0.27) |
65 |
|
Chronic |
27 |
-0.37(-0.55 to -0.19) |
54 |
|
Active treatment |
|||
|
|
|||
|
Acute |
10 |
-1.63 (-2.11 to -1.15) |
73 |
|
Chronic |
42 |
-0.88 (-1.03 to -0.74) |
45 |
|
|
|||
|
Krogsbøll et al. BMC Medical Research Methodology 2009 9:1 doi:10.1186/1471-2288-9-1 |
|||
